$4.66
0.00%
Nasdaq, Fri, Oct 02 2026.
ISIN
NL0015436031
Symbol
CVAC
Reports
Quarter | Annual
Index
NASDAQ Composite
Sector
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology

CureVac N.V. Stock News

Negative
CureVac N.V.
●
Reuters
●
5 months ago
CureVac sues Moderna for patent infringement over COVID-19 vaccines
German biotech company CureVac sued Moderna in Delaware federal court on Friday, alleging ​that Moderna's COVID-19 vaccine Spikevax infringed CureVac ‌patents related to messenger RNA (mRNA) technology.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today